Dyslipidemia: High blood lipid levels, such as high cholesterol. Cardiovascular disease. Stroke. Arthritis. Is diabetes a comorbidity? Among the various comorbidities like hypertension, cardiovascular disease and chronic obstructive pulmonary disease,diabetes considered as one of the critical comorbidity, whi...
Numerous clinical studies with objectives such as mortality and morbidity of cardiovascular (CV) have reported the benefit of treatment for dyslipidemia with lipid-lowering therapy, in particular using the statins. But the trials conducted in past years did not consider the gender differences of ...
Medical textbooks have always taught—and clinical practice correspondingly operates on the supposition—that type 2 diabetes can only “inexorably progress.” The belief is that once a patient with diabetes requires pharmacointervention, the disease is intractable. This long-entrenched dogma is omnipresen...
Dyslipidemia is the most fundamental risk factor for atherosclerotic cardiovascular disease (ASCVD). In clinical practice, many commonly prescribed medications can alter the patient’s lipid profile and, potentially, the risk for ASCVD—either favorably or unfavorably. The dyslipidemia observed in type 2...
The need for the journal is identified in the epidemic of obesity, diabetes, dyslipidemias and related diseases, and a sudden increase in popular diets, as well as renewed interest in intermediary metabolism.Editorial Recent events that provide the rationale for a new Open Access journal, ...
By the time of evaluation for dyslipidemia, many patients have already undergone genotype and phenotype evaluation for ART and have been stable on a virologic-effective regimen that is tolerated. Because virologic suppression is a priority, it is reasonable to treat the lipid abnormalities on an ...
Experiments exploring metabolism and intestinal microbiome in a mouse model with dyslipidemia have shown that pine pollen wall (PW) intake prevents pathological changes in the liver and regulates bile acid, fat metabolism, SCFA content, and intestinal microbiome structure [47]. Apart from this, by ...
Xu et al. (2024) found that metabolic risk factors (namely, hypertension, dyslipidemia, and diabetes), especially among the elderly, women, and people who do not drink alcohol, mediate the relationship between PM2.5 and depressive symptoms in 7794 participants (Xu et al., 2024). Two studies...
Role of body visceral fat in hypertension and dyslipidemia among the diabetic and nondiabetic ethnic population of Tripura—A comparative study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491841/#:~:text=Body%20visceral%20fat%20is%20generally,risk%20of%20serious%20health%20problems. ...
Female sex, diabetes, and dyslipidemia were independent predictors of restenosis or occlusion after the two procedures. A subsequent outcome meta-analysis concluded that >70% restenosis after CAS did not increase late ipsilateral stroke risk, suggesting routine duplex surveillance offers little benefit to...